Science & Enterprise subscription

Follow us on Twitter

  • A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
    about 29 mins ago
  • New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
    about 32 mins ago
  • If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
    about 17 hours ago
  • New post on Science and Enterprise: Essay – Ten Years and Counting https://t.co/bIFz5ld4g4 #Science #Business
    about 17 hours ago
  • A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infectio… https://t.co/auyvJKhyBq
    about 19 hours ago

Please share Science & Enterprise

Early Venture Investors Aim for Diverse Entrepreneurs

Business ideas graphic

A new venture investment company is funding start-ups at their earliest stages, with a goal of increasing support for entrepreneurs from all backgrounds. . . . → Read More: Early Venture Investors Aim for Diverse Entrepreneurs

Single Sensor to Detect Covid-19, Flu in Works

A university engineering team is developing an electronic sensor to quickly detect and distinguish between Covid-19 and influenza viruses. . . . → Read More: Single Sensor to Detect Covid-19, Flu in Works

Amazon Opens $2 Billion Climate Investment Fund

Amazon van at wind farm

Retailing and web services giant Amazon plans to invest $2 billion in sustainable technologies to meet the company’s goal of becoming carbon neutral by 2040. . . . → Read More: Amazon Opens $2 Billion Climate Investment Fund

Fast Covid-19 Antibody Test Gets BARDA Funds

Drop of blood

A company developing point-of-care diagnostics is receiving a federal government contract for a one-drop blood test that detects Covid-19 virus antibodies in five minutes. . . . → Read More: Fast Covid-19 Antibody Test Gets BARDA Funds

Gene, Cell Therapy Start-Up Gains $700M in Early Funds

Stem cells

A biotechnology company creating engineered cells with modified genes for treating disease is raising $700 million in its first venture finance round. . . . → Read More: Gene, Cell Therapy Start-Up Gains $700M in Early Funds

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure

Partnership to Speed Covid-19 Clinical Trials

Global Covid-19

A company that aims to accelerate clinical trials is partnering with an entrepreneur and researcher to speed up the pace of new trials of Covid-19 vaccines, therapies, and diagnostics. . . . → Read More: Partnership to Speed Covid-19 Clinical Trials

Crispr Heart Disease Start-Up Raises New $63M

Heart, circulation system

A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round. . . . → Read More: Crispr Heart Disease Start-Up Raises New $63M

Challenge Seeks Class of 2020 Covid-Inspired Companies

Workers by office window

A new challenge competition aims to recognize start-up companies founded by university students getting their undergraduate degrees this year. . . . → Read More: Challenge Seeks Class of 2020 Covid-Inspired Companies

Foundations Back ALS Biomarker Study

Neuron

Two organizations supporting research on amyotrophic lateral sclerosis or ALS are funding a study of changes to chemical indicators in the body responding to ALS drugs. . . . → Read More: Foundations Back ALS Biomarker Study